System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Doron Aronson is an expert in Cardiology at Rambam Health Care Campus (Israel). As of October 2026, ScienceLeadR ranks Doron Aronson in the top 1% of experts worldwide for Heart Failure. Doron Aronson has authored 279 publications, the most recent in 2026, and is an investigator in 13 clinical trials, 2 of them ongoing. SLR score: 1,074 (community average: 125). How the SLR is computed.

LeadR Profile

Doron Aronson Rambam Health Care Campus Israel
1 074 ScienceLeadR Reputation 1074

Unlock

Register Login
Network Map

Cardiology

Subspecialties: Medical Imaging - Biochemistry - Public Health

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1997 - 2026
Source: PubMed

Rambam Health Care Campus

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 279

Citations

Citations: 38 364 1st author: 78 Last author: 68 Unique author: 17

Main journals

Am J Cardiol 28
J Am Coll Cardiol 14
Eur Heart J 11
Int J Cardiol 11
J Card Fail 11

Best Journals

N Engl J Med 7
Eur Heart J 2
JAMA 1

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Kidney function and acid-base status as gatekeepers of natriuretic and diuretic responsiveness in chronic HF: insights from the DEA-HF clinical trial.
PMID 42149589 — acetazolamide, diuresis, safety, serum, kidney, natriuresis, metolazone, diuretics, therapeutics, furosemide		Eur Heart J Cardiovasc Pharmacother20260
Seasonal variation in cardiovascular and cerebrovascular hospitalizations across climatic zones in Northern and Southern Israel.
PMID 41872790 — hospitalization, cardiovascular diseases		BMC Cardiovasc Disord20260
Efficacy of ambulatory intravenous diuresis for chronic heart failure patients: Insights from the DEA-HF trial.
PMID 40660874 — diuresis, safety, hospitalization, heart failure, heart, diuretics, therapeutics, furosemide		ESC Heart Fail20250
Left atrial functional impairment as a predictor of atrial fibrillation: insights from cardiac CT.
PMID 39838087 — radiography, atrial function, atrial fibrillation		Eur Radiol20250
Thromboembolic Complications in Takotsubo Cardiomyopathy.
PMID 39379040 — ventricular function, left, stress, physiological, recycling, thrombosis, ventricular function, hemostasis, cardiomyopathies, takotsubo cardiomyopathy		Semin Thromb Hemost20242

Clinical Studies 13

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 1 Study Director: 1

By phase:

Phase 3 6
N/A 4
Phase 2/Phase 3 2
Phase 2 1

By status:

Completed 8
Recruiting 2
Terminated 2
Unknown 1

By type:

Interventional 12
Observational 1

By Monocentric/Multicentric:

monocentric 5
multicentric2to4 2
multicentric5to9 0
multicentricup10 6

Main Topics

Ongoing Clinical Trials

2 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Reducing Fluid Overload in Heart Failure Patients Using a Non invasive Renal Independent System
NCT06360380 — safety, heart failure, heart, vital signs, signs and symptoms, therapeutics		N/ARecruiting2024
Safety and Performance Evaluation of the Nephronyx System for the Treatment of Patients With ADHF
NCT05759806 — safety, heart failure, heart, therapeutics		N/ARecruiting2022

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS